MENU
EDSA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Edesa Biotech (EDSA) Earnings Date & Reports
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases... Show more
A.I. Advisor
published Earnings
EDSA is expected to report earnings to fall 5.00% to -56 cents per share on December 11
Q3'26
Est.
$-0.57
Q2'26
Missed
by $0.22
Q1'26
Missed
by $0.11
Q4'25
Beat
by $0.03
Q3'25
Beat
by $0.24
The last earnings report on August 13 showed earnings per share of -60 cents, missing the estimate of -37 cents. With 8.50K shares outstanding, the current market capitalization sits at 27.48M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a biopharmaceutical company, which focuses on acquiring, developing and commercializing clinical stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs.
Industry Biotechnology
Industry
N/A
Address
100 Spy Court
Phone
+1 289 800-9600
Employees
17
Web
https://www.edesabiotech.com